{"disease":{"id":"locally-advanced-adrenal-cortex-carcinoma","name":"locally advanced adrenal cortex carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06006013","title":"Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":21,"lead_sponsor_name":"Emory University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}